Bella Pharmaceuticals, Inc.
FDA inspection history across 2 sites, 2017 to 2019
- 1
- Close-out
- 1
- Form 483
Every document, by year
- Close-out
- Form 483
2017: one Form 483; 2019: one close-out letter.
The story so far
Built from the dates and citations on the documents themselves.
- 2017–19One Form 483 and one close-out letter, at Chicago, Illinois and Glenview, Illinois.
Cited most
Across all Bella Pharmaceuticals observations on file
- 21 CFR 211.42Design and construction features3
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.130Packaging and labeling operations1
- 21 CFR 211.165Testing and release for distribution1
- 21 CFR 211.167Special testing requirements1
The complete Bella Pharmaceuticals file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Glenview, Illinois
One close-out letter · 2019
Latest: Close-out, Feb 11, 2019 →Chicago, Illinois
One Form 483 · 2017 · 11 observations
Latest: Form 483, Jul 18, 2017 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2019-02-11 | Close-out Close-out letter | Glenview, Illinois | — | $99 |
| 2017-07-18 | 483 Form 483 | Chicago, Illinois | 11 | $99 |
Investigators on these documents
FEI number 3013442632 · most recent document Feb 11, 2019
About Bella Pharmaceuticals, Inc.
How many FDA Form 483s has Bella Pharmaceuticals, Inc. received?
FDA Intel has 1 Form 483 on file for Bella Pharmaceuticals, Inc.; the most recent is dated Jul 18, 2017.
When was Bella Pharmaceuticals, Inc. last inspected by FDA?
The most recent FDA inspection document on file for Bella Pharmaceuticals, Inc. is a Form 483 dated Jul 18, 2017, for the site in Chicago, Illinois.
What did FDA cite at Bella Pharmaceuticals, Inc.?
The regulations cited most in the observations on file for Bella Pharmaceuticals, Inc. are 21 CFR 211.42 (Design and construction features), 3 times; 21 CFR 211.113 (Control of microbiological contamination), 1 time; 21 CFR 211.130 (Packaging and labeling operations), 1 time.